Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | RAC2 | P15153 | 1/20 | 0.33 |
| ▸ | RAC3 | P60763 | 1/20 | 0.33 |
| ▸ | CDC42 | P60953 | 1/20 | 0.33 |
| ▸ | RAC1 | P63000 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.32 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.31 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17232214 | 0.97 | LIMK1 (0.35) | ALOX5RAC2RAC3CDC42RAC1 | |
| SCHEMBL18562286 | 0.96 | KDM4E (0.36) | ALOX5RAC2RAC3CDC42RAC1 | |
| SCHEMBL22023764 | 0.96 | KDM4E (0.36) | ALOX5RAC2RAC3CDC42RAC1 | |
| SCHEMBL18562284 | 0.95 | ALOX5 (0.38) | ALOX5RAC2RAC3CDC42RAC1 | |
| SCHEMBL25714305 | 0.95 | ALOX5 (0.41) | ALOX5KDM4EATML3MBTL1LIMK1 | |
| SCHEMBL25928497 | 0.95 | ALOX5 (0.36) | ALOX5KDM4EATML3MBTL1LIMK1 | |
| SCHEMBL22329225 | 0.95 | ALOX5 (0.38) | ALOX5KDM4EATML3MBTL1LIMK1 | |
| SCHEMBL25928708 | 0.95 | ALOX5 (0.38) | ALOX5RAC2RAC3CDC42RAC1 | |
| SCHEMBL17231991 | 0.95 | ALOX5 (0.36) | ALOX5RAC2RAC3CDC42RAC1 | |
| SCHEMBL20922058 | 0.94 | ALOX5 (0.38) | ALOX5RAC2RAC3CDC42RAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3533794-B1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2022-02-23 | — | — | EP | disclosed |
| US-10985330-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2021-04-20 | — | — | US | disclosed |
| EP-3533794-A2 | MATERIALS FOR ELECTRONIC DEVICES | Merck Patent GmbH (DE) | 2019-09-04 | — | — | EP | disclosed |
| US-10355223-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2019-07-16 | — | — | US | disclosed |
| EP-3137458-B1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2019-04-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10355223-B2 | Materials for electronic devices | EPHA3, EPHA6, DDT | ALOX5 3691/4885RAC2 361/4885RAC3 246/4885 |
| US-10985330-B2 | Materials for electronic devices | EPHA3, EPHA6, DDT | ALOX5 3691/4885RAC2 361/4885RAC3 246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.